4:持股變動聲明-高管 ROSENWALD LINDSAY A MD
4:持股變動聲明-董事 Klein Dov
SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(11.2%)
S-3:特定交易註冊聲明
144:擬議出售證券
10-Q:季度報表
8-K:豐澤生物科技公佈2024年第一季度財務業績和近期公司亮點
SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(8.0%)
4:持股變動聲明-股東 Fortress Biotech, Inc.
Fortress Biotech Inc Series A P | DEFA14A:其他
Fortress Biotech Inc Series A P | DEF 14A:股東委託書決議
Fortress Biotech Inc Series A P | 424B3:募資說明書
Fortress Biotech Inc Series A P | 4:持股變動聲明-高管 Jin David
Fortress Biotech Inc Series A P | 8-K:重大事件
Fortress Biotech Inc Series A P | 10-K:年度報表
Fortress Biotech Inc Series A P | SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(7.5%)
Fortress Biotech Inc Series A P | 4:持股變動聲明-股東 Fortress Biotech, Inc.
Fortress Biotech Inc Series A P | SC 13G/A:超過5%持股股東披露文件(修正)-Nantahala Capital Management, LLC(4.2%),Wilmot B. Harkey(4.2%)等
Fortress Biotech Inc Series A P | 8-K:重大事件
Fortress Biotech Inc Series A P | 4:持股變動聲明-高管 ROSENWALD LINDSAY A MD
暫無數據